Skip to main content
Saniona logo

Saniona — Investor Relations & Filings

Ticker · SANION ISIN · SE0005794617 LEI · 549300XO4L9XNOCFCZ84 ST Manufacturing
Open in API
Filings indexed 298 across all filing types
Latest filing 2020-03-26 Regulatory Filings
Country SE Sweden
Listing ST SANION

About Saniona

http://saniona.com

Saniona is a clinical-stage biopharmaceutical company focused on the research and development of treatments for neurological disorders, with a primary emphasis on epilepsy. The company is a leader in the field of ion channel modulation, leveraging its expertise and a proprietary drug discovery engine to create new medicines. Saniona has developed an extensive library of over 20,000 proprietary molecules designed to target various ion channels. Its pipeline includes multiple potential new medicines advancing through clinical trials, with the goal of addressing unmet medical needs for patients with central nervous system diseases.

Recent filings

Filing Released Lang Actions
Saniona enters into second collaboration agreement with Boehringer Ingelheim in schizophrenia
Regulatory Filings Classification · 95% confidence The document is a press release announcing a new research collaboration and licensing agreement between Saniona and Boehringer Ingelheim. It details the financial terms (milestones and royalties) and the strategic nature of the partnership. Since this is a corporate announcement regarding a business development/partnership deal rather than a financial report, a dividend notice, or a regulatory filing, it falls under the general category of regulatory announcements/press releases. Given the specific nature of the announcement, 'RNS' (Regulatory Filings) is the most appropriate fallback category for this type of corporate news release.
2020-03-26 English
Saniona Announces Management Transition to Support Strategic Transformation
Board/Management Information Classification · 100% confidence The document is a press release announcing changes to the company's senior management team, specifically the appointment of an interim CFO and a new Deputy CEO. This aligns perfectly with the definition for Board/Management Information (MANG).
2020-03-24 English
Saniona meddelar ledningsförändring för att stödja strategisk omvandling
Board/Management Information Classification · 100% confidence The document is a press release announcing changes to the company's senior management team, specifically the appointment of an interim CFO and a new Deputy CEO. This aligns perfectly with the definition for Board/Management Information (MANG).
2020-03-24 Swedish
Saniona’s announces last day of trading in BTU and first day of trading in warrants of series TO 1, TO 2 and TO 3
Share Issue/Capital Change Classification · 95% confidence The document is a press release announcing the final trading day for paid subscription units (BTU) and the commencement of trading for new warrants (TO 1, TO 2, and TO 3) following a rights issue. This relates directly to changes in the company's capital structure and the issuance of new financial instruments (warrants). Therefore, it falls under the category of Share Issue/Capital Change.
2020-03-11 English
Saniona meddelar sista dag för handel i BTU samt första dag för handel i teckningsoptioner av serie TO 1, TO 2 och TO 3
Share Issue/Capital Change Classification · 95% confidence The document is a press release from Saniona AB regarding the final trading day for 'BTU' (paid subscribed units) and the first trading day for new warrants (TO 1, TO 2, and TO 3) following a rights issue. This relates to changes in the company's capital structure and the issuance of new financial instruments. According to the provided definitions, announcements regarding new share issues, stock splits, or other capital changes fall under the 'SHA' category.
2020-03-11 Swedish
Sanionas vederlagsfria företrädesemission av units övertecknad
Capital/Financing Update Classification · 95% confidence The document is a press release from Saniona AB announcing the results of a rights issue (företrädesemission) of units consisting of warrants. It details the subscription outcome, allocation principles, and future trading plans for the warrants. This falls under the category of capital structure changes and financing activities, specifically related to share/warrant issuance.
2020-03-04 Swedish

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.